MUCOSAL ABETA VACCINATION; MODULATING THE IMMUNE RESPONSE
MUCOSAL ABETA VACCINATION; MODULATING THE IMMUNE RESPONSE
批准号:
7349532
负责人:
CYNTHIA A LEMERE
金额:
$3.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-01 至 2007-04-30
中文摘要
这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金,因此可能会出现在其他CRISE条目中。列出的机构是针对中心的,而不一定是针对调查员的机构。Aβ免疫疗法具有预防和可能治疗人类阿尔茨海默病(AD)的潜力。对基因工程AD小鼠模型的研究一直表明,Abeta疫苗在降低中枢Abeta和改善认知方面都有效,没有任何不良影响。然而,在大约6%的患者中,第一次人类临床试验因脑膜脑炎而停止;识别全长Abeta免疫原作为一种自身蛋白可能是导致这些不良事件的原因。非人灵长类动物,包括加勒比海扇贝(ChlorOcean Bus Athiiops),与人类具有相同的淀粉样前体蛋白(APP)和Abeta,并有与年龄相关的脑斑块沉积。因此,它们可能成为研究Abeta清除和对Abeta疫苗免疫反应的较好动物模型。我们正在为认知功能的行为测试进行培训,并将在接下来的几个月内开始接种Abeta疫苗。我们的目标是表征一种新型Abeta疫苗的体液和细胞免疫反应,并确定S疫苗在降低神经系统内Abeta和改善认知方面的有效性。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Abeta immunotherapy has potential for preventing and possibly treating Alzheimer¿s disease (AD) in humans. Studies in genetically-engineered AD mouse models have consistently demonstrated efficacy of the Abeta vaccine both in lowering CNS Abeta and improving cognition without any adverse effects. However, the first human clinical trial was halted due to meningoencephalitis in approximately 6% of patients; recognition of the full-length Abeta immunogen as a self-protein may have attributed to these adverse events. Non-human primates, including Caribbean vervets (Chlorocebus aethiops), have the same amyloid precursor protein (APP) and Abeta as humans, and have age-related cerebral plaque deposition. Thus, they may serve as a better animal model for studying Abeta clearance and immune responses to Abeta vaccination. We are training vervets for behavioral testing of cognitive functions and will begin Abeta vaccination in the next several months. Our goals are to characterize the humoral and cellular immune responses to a novel Abeta vaccine and to determine the vaccine¿s efficacy in lowering Abeta within the nervous system and improving cognition.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Generation of a Complement C3 Conditional Knockout Mouse
-
批准号:8741912
-
项目类别:
-
资助金额:$20.71万
-
财政年份:2013
-
负责人:CYNTHIA A LEMERE
-
依托单位:
Generation of a Complement C3 Conditional Knockout Mouse
-
批准号:8638529
-
项目类别:
-
资助金额:$26.82万
-
财政年份:2013
-
负责人:CYNTHIA A LEMERE
-
依托单位:
Pyroglutamate Amyloid-beta as an Immunotherapeutic Target for Alzheimer's Disease
-
批准号:8371341
-
项目类别:
-
资助金额:$33.7万
-
财政年份:2012
-
负责人:CYNTHIA A LEMERE
-
依托单位:
Pyroglutamate Amyloid-beta as an Immunotherapeutic Target for Alzheimer's Disease
-
批准号:8702980
-
项目类别:
-
资助金额:$33.89万
-
财政年份:2012
-
负责人:CYNTHIA A LEMERE
-
依托单位:
Pyroglutamate Amyloid-beta as an Immunotherapeutic Target for Alzheimer's Disease
-
批准号:8724023
-
项目类别:
-
资助金额:$15.58万
-
财政年份:2012
-
负责人:CYNTHIA A LEMERE
-
依托单位:
Pyroglutamate Amyloid-beta as an Immunotherapeutic Target for Alzheimer's Disease
-
批准号:8897932
-
项目类别:
-
资助金额:$33.81万
-
财政年份:2012
-
负责人:CYNTHIA A LEMERE
-
依托单位:
Pyroglutamate Amyloid-beta as an Immunotherapeutic Target for Alzheimer's Disease
-
批准号:8531819
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2012
-
负责人:CYNTHIA A LEMERE
-
依托单位:
Mucosal Abeta Vaccination: Modulating the Immune Response
-
批准号:7908075
-
项目类别:
-
资助金额:$34.52万
-
财政年份:2009
-
负责人:CYNTHIA A LEMERE
-
依托单位:
Mucosal Abeta Vaccination: Modulating the Immune Response
-
批准号:7847751
-
项目类别:
-
资助金额:$4.67万
-
财政年份:2009
-
负责人:CYNTHIA A LEMERE
-
依托单位:
ACTIVE ABETA IMMUNIZATION IN VERVETS
-
批准号:7715450
-
项目类别:
-
资助金额:$5.52万
-
财政年份:2008
-
负责人:CYNTHIA A LEMERE
-
依托单位:
MUCOSAL ABETA VACCINATION; MODULATING THE IMMUNE RESPONSE
-
批准号:7165597
-
项目类别:
-
资助金额:$3.35万
-
财政年份:2005
-
负责人:CYNTHIA A LEMERE
-
依托单位:
MUCOSA ABETA VACCINATION; MODULATING THE IMMUNE RESPONSE
-
批准号:6971400
-
项目类别:
-
资助金额:$3.55万
-
财政年份:2004
-
负责人:CYNTHIA A LEMERE
-
依托单位:
Mucosal Abeta Vaccination: Modulating the Immune Response
-
批准号:7569348
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2001
-
负责人:CYNTHIA A LEMERE
-
依托单位:
Mucosal ABeta Vaccination/Modulating the Immune Response
-
批准号:6420693
-
项目类别:
-
资助金额:$41.71万
-
财政年份:2001
-
负责人:CYNTHIA A LEMERE
-
依托单位:
Mucosal ABeta Vaccination: Modulating the Immune Respon*
-
批准号:6775520
-
项目类别:
-
资助金额:$42.04万
-
财政年份:2001
-
负责人:CYNTHIA A LEMERE
-
依托单位:
Mucosal ABeta Vaccination: Modulating the Immune Respon*
-
批准号:6532582
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2001
-
负责人:CYNTHIA A LEMERE
-
依托单位:
Mucosal ABeta Vaccination: Modulating the Immune Respon*
-
批准号:6604114
-
项目类别:
-
资助金额:$42.04万
-
财政年份:2001
-
负责人:CYNTHIA A LEMERE
-
依托单位:
Mucosal Abeta Vaccination: Modulating the Immune Response
-
批准号:7213545
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2001
-
负责人:CYNTHIA A LEMERE
-
依托单位:
Mucosal Abeta Vaccination: Modulating the Immune Response
-
批准号:7795028
-
项目类别:
-
资助金额:$32.09万
-
财政年份:2001
-
负责人:CYNTHIA A LEMERE
-
依托单位:
Mucosal Abeta Vaccination: Modulating the Immune Response
-
批准号:7341660
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2001
-
负责人:CYNTHIA A LEMERE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于HSCs-中性粒细胞间Abeta/CD11b/RAGE正反馈环路介导的NETs形成探讨四逆散增效PD-1/PD-L1抑制剂抗肝癌的作用及机制
-
批准号:82374223
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:汪思亮
-
依托单位:
Abeta与PMPCB结合阻碍MMP的形成和线粒体蛋白前体的加工成熟及机制研究
-
批准号:81971000
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:王文安
-
依托单位:
基于ABeta聚集体重组与表面伪装策略的抗AD药物设计合成及活性研究
-
批准号:81973174
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:卜宪章
-
依托单位:
TREM2在红花黄色素调节小胶质细胞活化改善Abeta病理变化中的作用机理研究
-
批准号:81960665
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2019
-
负责人:胡艳丽
-
依托单位:
外周源性Abeta在阿尔茨海默病发生中的作用和机制研究
-
批准号:81701043
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卜先乐
-
依托单位:
辣椒素对Abeta产生的调控作用及机制研究
-
批准号:81600949
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:王俊
-
依托单位:
牛蒡子苷元的结构修饰及其降Abeta含量的构效关系研究
-
批准号:81473110
-
项目类别:面上项目
-
资助金额:110.0万元
-
批准年份:2014
-
负责人:胡立宏
-
依托单位:
APOC1,CLU,SORL1,APOE变异通过调控脂代谢和Abeta水平影响痴呆发病机理的研究
-
批准号:81460203
-
项目类别:地区科学基金项目
-
资助金额:47.0万元
-
批准年份:2014
-
负责人:胡才友
-
依托单位:
虾青素对Abeta神经毒性的抑制作用及其分子作用机制
-
批准号:31201338
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:赵燕
-
依托单位:
下调磷酸酯酶2A抑制因子降低Abeta的机制及其神经保护作用的研究
-
批准号:81270418
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:张家玉
-
依托单位: